63502-89-6

Usage

Uses

Used in Biochemical Research:
3-Hydroxybenzamidine hydrochloride is used as a laboratory reagent for studying the structure and function of serine proteases due to its ability to act as a reversible inhibitor.
Used in Pharmaceutical Development:
3-Hydroxybenzamidine hydrochloride is used as a key component in the synthesis of other bioactive compounds and pharmaceuticals, contributing to the development of new therapeutic agents.
Used in Therapeutic Applications:
3-Hydroxybenzamidine hydrochloride is used as a potential anticoagulant and antiplatelet agent, being studied for its therapeutic applications in the prevention and treatment of blood clot-related conditions.

Upstream product

• 873-62-1 m-cyanophenol 

Downstream Products

• 91272-21-8 2-(m-hydroxyphenyl)-5,6-pentamethylenepyrimidin-4(3H)-one 
• 210962-28-0 N-t-butoxycarbonyl-3-hydroxybenzamidine 
• 1403575-02-9 3-(5-dodecylpyrimidin-2-yl)phenol 
• 1199943-05-9 3-[4-(trans-4-hydroxy-cyclohexylamino)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]-phenol 
• 1199943-04-8 3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-phenol 
• 1199943-03-7 2-(3-hydroxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-ol 

Relevant academic research and scientific papers

Towards room temperature ionic liquid crystals: Linear versus bent imidazolium phenylpyrimidines

The synthesis and the mesomorphic properties of novel imidazolium salts with mesogenic 2-phenylpyrimidine or 2-alkylpyrimidinecarboxylic acid central cores are reported. The mesogenic units are connected to the imidazolium head groups via an alkoxy spacer

HYDROXYPHENYL-SUBSTITUTED PYRROLO[2,3d]PYRIMIDINE DERIVATIVES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS

Novel compounds are described of the general formula (I), which are selective antagonists of the adenosine A1 receptor and wherein the substituents R1 have the meanings given in the description,and also medicaments containing these c

BENZAMIDINE DERIVATIVES

Benzamidine derivatives of the following formulae or analogs thereof, i. e., pharmaceutically acceptable salts thereof, are provided. These compounds or salts thereof have a blood-coagulation inhibiting effect based on an excellent effect of inhibiting the action of activated blood coagulation factor X, and they are useful as anticoagulants.